Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Indoco Remedies Ltd (INDOCO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C2819
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervous system, respiratory, anti infective, ophthalmic, cardiovascular, antiinflammatory, anti- diabetics, dental care, pain management, gastrointestinal, anti obesity, musculo-skeletal, nutrition and others. Indoco operates its manufacturing facilities for finished dosages and APIs supported by research and development centre spread across India. The company has operations and market presence in Europe, the US, Latin America, Asia, Africa, and other CIS countries. Indoco Remedies is headquartered in Mumbai, Maharashtra, India.

Indoco Remedies Ltd (INDOCO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 11
Private Equity 12
Baring Private Equity Partners Acquires 3.4% Stake In Indoco Remedies For US$1.7 Million 12
Partnerships 13
DSM Pharma Enters Into Co-Marketing Agreement With Indoco Remedies For APIs 13
Acquisition 14
Barclays Merchant Bank Acquires Stake in Indoco Remedies from Baring Private Equity Partners India 14
Indoco Remedies Ltd – Key Competitors 15
Indoco Remedies Ltd – Key Employees 16
Indoco Remedies Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Indoco’s Net Profit at Rs 19.76 Crores 18
Aug 09, 2017: Indoco Remedies reports Q1 fiscal 2018 results 19
Legal and Regulatory 20
May 18, 2018: Indoco Remedies Completes US FDA Inspection at API Manufacturing Facility In Mumbai 20
Mar 27, 2018: Indoco Remedies: UK-MHRA inspection report 21
Feb 15, 2018: Indoco Remedies: EU GMP Certification of Goa Plant III 22
Feb 12, 2018: Indoco Remedies: USFDA Inspection of Goa Plant 1 23
Mar 31, 2017: indoco remedies Provides Update On US FDA Inspection At Drug Manufacturing Facility In Goa 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Indoco Remedies Acquires Clinical Research Division from Piramal Enterprises 11
Baring Private Equity Partners Acquires 3.4% Stake In Indoco Remedies For US$1.7 Million 12
DSM Pharma Enters Into Co-Marketing Agreement With Indoco Remedies For APIs 13
Barclays Merchant Bank Acquires Stake in Indoco Remedies from Baring Private Equity Partners India 14
Indoco Remedies Ltd, Key Competitors 15
Indoco Remedies Ltd, Key Employees 16
Indoco Remedies Ltd, Subsidiaries 17

List of Figures
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Indoco Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BT Global Services Limited:企業の戦略的SWOT分析
    BT Global Services Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Riyad Bank:企業の戦略・SWOT・財務情報
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • OJSC AK BARS Bank:企業の戦略・SWOT・財務情報
    OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report Summary OJSC AK BARS Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Saudi Arabian Oil Co (2222):企業の財務・戦略的SWOT分析
    Saudi Arabian Oil Co (2222) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • NovoCure Ltd (NVCR):企業の財務・戦略的SWOT分析
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Mesa Laboratories Inc (MLAB):企業の財務・戦略的SWOT分析
    Summary Mesa Laboratories Inc (Mesa) is a medical device company. It manufactures and markets validation and monitoring instruments. The company’s products include mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap t …
  • Torax Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TORAX Medical Inc (Torax Medical), a subsidiary of Ethicon US LLC, is a healthcare company that offers technology solutions. The company offers LINX reflux management system, a clinical stage medical device. Torax Medical offers treatment for gastro esophageal reflux disease that can turn in …
  • Safaricom Ltd
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Univision Communications Inc.:企業の戦略的SWOT分析
    Univision Communications Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Guangshen Railway Company Limited:企業の戦略・SWOT・財務情報
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Congenica Ltd-医療機器分野:企業M&A・提携分析
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers research and experimental development on biotechnology. The company’s technology SAPIENTIA, is used to personalize patient care through accurate diagnoses, support clinical trials, and drug development. It offers services such …
  • Aquinox Pharmaceuticals Inc (AQXP):企業の財務・戦略的SWOT分析
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conv …
  • Didion Milling Inc.:企業の戦略・SWOT・財務情報
    Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report Summary Didion Milling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Uranium One Inc:企業の戦略的SWOT分析
    Uranium One Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • The Aerospace Corp:企業の戦略的SWOT分析
    The Aerospace Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Idaho Power Co:企業の戦略的SWOT分析
    Idaho Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Itamar Medical Ltd (ITMR):企業の財務・戦略的SWOT分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that develops, manufactures, and markets non-invasive medical devices for the diagnosis of cardiology disease and sleep related breathing disorders. The company develops products using its proprietary peripheral arterial tonomet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆